Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

Feb 23, 2008·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·Matthew Breen, Jaime F Modiano

Directional genomic hybridization for chromosomal inversion discovery and detection

Apr 11, 2013·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·F Andrew RaySusan M Bailey

LQB-118, a pterocarpanquinone structurally related to lapachol [2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone]: a novel class of agent with high apoptotic effect in chronic myeloid leukemia cells

May 26, 2010·Investigational New Drugs·Raquel C MaiaPaulo R R Costa

Cryptotanshinone induces cell cycle arrest and apoptosis of multidrug resistant human chronic myeloid leukemia cells by inhibiting the activity of eukaryotic initiation factor 4E

May 23, 2012·Molecular and Cellular Biochemistry·Yuqing GeZhe Chen

Treatment selection after imatinib resistance in chronic myeloid leukemia

Apr 4, 2009·Targeted Oncology·Elias JabbourHagop M Kantarjian

Mechanisms and impacts of chromosomal translocations in cancers

Aug 7, 2012·Frontiers of Medicine·Jing H Wang

The role of RAS effectors in BCR/ABL induced chronic myelogenous leukemia

Nov 23, 2013·Frontiers of Medicine·Jessica Fredericks, Ruibao Ren

Chronic myeloid leukemia: overview of new agents and comparative analysis

Apr 11, 2013·Current Treatment Options in Oncology·Preetesh JainJorge Cortes

Second-generation tyrosine kinase inhibitors as therapy for chronic myeloid leukemia

May 1, 2007·Current Hematologic Malignancy Reports·Ronan SwordsFrancis J Giles

New approaches to the management of Philadelphia-chromosome-positive acute lymphocytic leukemia

Jul 1, 2007·Current Hematologic Malignancy Reports·Deborah A ThomasHagop M Kantarjian

Chronic myelogenous leukemia stem cells: What's new?

Apr 29, 2010·Current Hematologic Malignancy Reports·Mhairi Copland

Role of tyrosine kinase inhibitors in the management of Philadelphia chromosome-positive acute lymphoblastic leukemia

Jun 11, 2011·Current Hematologic Malignancy Reports·Michael S MathisenFarhad Ravandi

Role of epigenetics in chronic myeloid leukemia

Jan 9, 2013·Current Hematologic Malignancy Reports·Katerina Machova PolakovaTomas Stopka

STI571: a gene product-targeted therapy for leukemia

Apr 11, 2001·Current Oncology Reports·Michael J Mauro, Brian J Druker

Philadelphia-positive acute lymphoblastic leukemia: current treatment options

Jun 7, 2012·Current Oncology Reports·Theresa Liu-DumlaoFarhad Ravandi

Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease

Aug 22, 2008·Immunologic Research·Valerie I BrownStephan A Grupp

miR-153 sensitized the K562 cells to As2O3-induced apoptosis

Jan 27, 2011·Medical Oncology·Li LiuYingmin Liang

Analysis of the clinico-hematological relevance of the breakpoint location within M-BCR in chronic myeloid leukemia

Dec 28, 2012·Medical Oncology·Ayda BennourHalima Sennana

Failure of copy Imatib (CIPLA, India) to maintain hematologic and cytogenetic responses in chronic myeloid leukemia in chronic phase

Jan 8, 2010·International Journal of Hematology·Mervat Mattar

Classification and diagnosis of myeloproliferative neoplasms according to the 2008 World Health Organization criteria

Mar 2, 2010·International Journal of Hematology·Martha Wadleigh, Ayalew Tefferi

Cardiovascular differentiation of imatinib and bosutinib in the rat

Oct 22, 2013·International Journal of Hematology·Jonathan R HeyenBart Jessen

Hematopoiesis, myeloid leukemia and growth factors

Jan 1, 1988·The International Journal of Biochemistry·L C OlsenI F Pryme

In vitro mammalian mutagenesis as a model for genetic lesions in human cancer

Nov 16, 1992·Mutation Research·J HozierM M Moore

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

Jan 1, 1984·Cell·J GroffenG Grosveld

Involvement of chromosome 9 in variant Ph1 translocation

Jan 1, 1985·Leukemia Research·C R BartramE Kleihauer

Complexity of an apparently simple variant Ph translocation in chronic myeloid leukemia

Jan 1, 1987·Leukemia Research·C Morris, P H Fitzgerald

Changing p53 mutations with the evolution of chronic myeloid leukaemia from the chronic phase to blast crisis

Aug 1, 1995·Leukemia Research·B A GuinnK I Mills

Spontaneous granulocyte-macrophage colony growth by peripheral blood mononuclear cells in myeloproliferative disorders

Feb 1, 1996·Leukemia Research·T SiitonenP Koistinen

All-trans retinoic acid combined with interferon-alpha effectively inhibits granulocyte-macrophage colony formation in chronic myeloid leukemia

Mar 1, 1996·Leukemia Research·A ZhengP Koistinen

The effect of bcr-abl antisense oligonucleotide on DNA synthesis and apoptosis in K562 chronic myeloid leukemia cells

Jun 1, 1996·Leukemia Research·P T RowleyB A Kosciolek

Increasing methylation of the calcitonin gene during disease progression in sequential samples from CML patients

Sep 1, 1996·Leukemia Research·K I MillsA K Burnett

The role of cellular oncogenes in cancers of non-viral etiology

Jan 1, 1985·Pharmacology & Therapeutics·M P Goldfarb

DNA repair in genes

Jan 1, 1988·Pharmacology & Therapeutics·V A Bohr, P C Hanawalt

Oncogene activation by chromosomal rearrangement in chronic myelocytic leukemia

Sep 1, 1987·Mutation Research·A de Klein

The role of multiple oncogenes in hematopoietic neoplasia

May 1, 1988·Mutation Research·R C Schwartz, O N Witte

Unusual translocation and chronic myelocytic leukemia: "masked" Philadelphia chromosome (Ph 1)

Nov 1, 1981·Cancer Genetics and Cytogenetics·M LessardA Fritz

Chromosomes and causation of human cancer and leukemia. XLV. Chromosome patterns in stimulated lymphocytes of chronic lymphocytic leukemia

Jun 1, 1981·Cancer Genetics and Cytogenetics·M MoritaA A Sandberg

New types of unusual and complex Philadelphia chromosome (Ph1) translocations in chronic myeloid leukemia

Jan 1, 1981·Cancer Genetics and Cytogenetics·G H Borgström

Karyotype evolution in a case of chronic myelogenous leukemia with an unusual Philadelphia chromosome translocation, t(4;22), and an additional translocation, t(3;5)

Jan 1, 1981·Cancer Genetics and Cytogenetics·M SessaregoE Salvidio

17p+ in a patient with chronic myelogenous leukemia (CML): its differentiation from an isochromosome 17,[i(17q)

Jan 1, 1981·Cancer Genetics and Cytogenetics·R S Verma, H Dosik

A complex variant Philadelphia (Ph1) chromosome translocation involving chromosomes No. 11, 14, and 22 in a case of chronic myelogenous leukemia

Oct 1, 1981·Cancer Genetics and Cytogenetics·J E KolitzT J Degnan

Cytogenetics of neoplasia of Xiphophorus

Apr 1, 1981·Cancer Genetics and Cytogenetics·K ChatterjeeF Anders

Translocation (9;11)(p21;q23) in three cases of acute monoblastic leukemia

Feb 1, 1982·Cancer Genetics and Cytogenetics·A HagemeijerJ Abels

Rearrangement in rDNA-bearing chromosomes in cell lines from neoplastic cells

May 1, 1982·Cancer Genetics and Cytogenetics·A S Henderson, S Megraw-Ripley

A photometric study of the standard Philadelphia (Ph1) translocation of chronic myeloid leukemia (CML)

Mar 1, 1982·Cancer Genetics and Cytogenetics·A W Wayne, J C Sharp

Cytogenetic studies in 56 cases with Ph1-positive hematologic disorders

Feb 1, 1982·Cancer Genetics and Cytogenetics·M Lessard, P Y Le Prisé

Multiple karyotypic changes in retinoblastoma tumor cells: presence of normal chromosome No. 13 in most tumors

Jul 1, 1982·Cancer Genetics and Cytogenetics·H A GardnerR A Phillips

Abnormalities of chromosome #13 in retinoblastomas from individuals with normal constitutional karyotypes

Jul 1, 1982·Cancer Genetics and Cytogenetics·G BalabanJ Shields

Chromosomal aberrations in chronic B-cell lymphocytic leukemia

Jun 1, 1982·Cancer Genetics and Cytogenetics·Gösta Gahrton, K H Robèrt

Chromosomal instability in ataxia telangiectasia

Aug 1, 1982·Cancer Genetics and Cytogenetics·P H KohnW R Levis

B-lymphoid cell involvement in chronic myelogenous leukemia: implications for the pathogenesis of the disease

Aug 1, 1982·Cancer Genetics and Cytogenetics·P J MartinP J Fialkow

Variant Philadelphia chromosome translocations in two patients with chronic myelogenous leukemia

Sep 1, 1982·Cancer Genetics and Cytogenetics·Joseph R TestaP H Wiernik

Karyotype evolution and tumor development

Feb 1, 1983·Cancer Genetics and Cytogenetics·T H Yosida

Chronic myelogenous leukemia with a Philadelphia chromosome resulting from a complex translocation (2; 9; 22), following an undifferentiated acute leukemia

Jan 1, 1983·Cancer Genetics and Cytogenetics·N SmadjaJ Debray

Novel reciprocal translocation between chromosomes 8 and 9 found in a patient with myeloproliferative disorder

Aug 1, 1983·Cancer Genetics and Cytogenetics·F FriedhoffT Alapatt

High resolution chromosomes of the t(9;22) positive leukemias

Apr 1, 1984·Cancer Genetics and Cytogenetics·O Prakash, J J Yunis

Cis-trans position effect in cancer translocations

Jul 1, 1984·Cancer Genetics and Cytogenetics·F Hecht, B K Hecht

The incidence, type, and subsequent evolution of 14 variant Ph1 translocations in 180 South African patients with Ph1-positive chronic myeloid leukemia

Jul 1, 1984·Cancer Genetics and Cytogenetics·R BernsteinB Mendelow

Is the chromosomal region 9q34 always involved in variants of the Ph1 translocation?

Sep 1, 1984·Cancer Genetics and Cytogenetics·A HagemeijerD Bootsma

Chronic myelogenous leukemia with a complex Ph1 translocation in an XYY male

Feb 1, 1984·Cancer Genetics and Cytogenetics·K OhyashikiA Tonomura

Chronic myeloid leukemia with a Philadelphia chromosome involving a t(21;22)

Jun 1, 1984·Cancer Genetics and Cytogenetics·P H PinkertonJ S Senn

Cytogenetic and immunologic phenotype findings in Hodgkin's disease

Mar 15, 1985·Cancer Genetics and Cytogenetics·I SlavutskyS B de Salum

Karyotypic analysis and chromosome polymorphisms in four choriocarcinoma cell lines

Apr 1, 1985·Cancer Genetics and Cytogenetics·D M SheppardS D Lawler

Variant Ph translocations in chronic myeloid leukemia

Nov 1, 1985·Cancer Genetics and Cytogenetics·S HeimF Mitelman

Unusual Ph translocations in CML: four new cases

Feb 15, 1985·Cancer Genetics and Cytogenetics·M SessaregoP Boccaccio

Myxoid chondrosarcoma with a translocation involving chromosomes 9 and 22

Jan 15, 1985·Cancer Genetics and Cytogenetics·S H HinrichsA E Freeman

Oncogenes and human cancer

Jan 15, 1985·Cancer Genetics and Cytogenetics·E Pimentel

Nomenclature: the Philadelphia chromosome or Ph without superscript

Jan 1, 1985·Cancer Genetics and Cytogenetics·A A SandbergF Hecht

Derivative 11 marker chromosome in bladder carcinoma

Apr 15, 1985·Cancer Genetics and Cytogenetics·R VanniE Usai

Unusual Ph translocations in the French prospective study on chronic myeloid leukemia. Groupe Français de Cytogénétique Hématologique

Apr 15, 1985·Cancer Genetics and Cytogenetics

Significance of secondary cytogenetic changes in patients with Ph-positive chronic granulocytic leukemia in the acute phase

Apr 1, 1986·Cancer Genetics and Cytogenetics·S SinghF W Gunz

The Philadelphia chromosome: a model of cancer and molecular cytogenetics

Mar 15, 1986·Cancer Genetics and Cytogenetics·A A SandbergF Hecht

High resolution banding of chronic myeloid leukemia chromosomes

Feb 15, 1986·Cancer Genetics and Cytogenetics·A N MohamedR S Chaganti

A new translocation in chronic myeloid leukemia--t(4;9;22)--resulting in a masked Philadelphia chromosome

Feb 1, 1986·Cancer Genetics and Cytogenetics·B LondonJ S Senn

Nonrandom chromosome structural aberrations and oncogene loci in human malignant melanoma

Feb 1, 1986·Cancer Genetics and Cytogenetics·M I PedersenN Wang

Dicentric chromosome 17 in patients with leukemia

Sep 1, 1986·Cancer Genetics and Cytogenetics·Joseph R Testa, B C Cohen

A possible case of chronic leukoerythroblastosis associated with t(12;14)(p13;q22) in bone marrow cells

Jul 1, 1986·Cancer Genetics and Cytogenetics·D A CouzinG S Stephen

Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations

Jun 1, 1986·Cancer Genetics and Cytogenetics·S H BignerD D Bigner

Specific chromosome anomalies and predisposition to human breast, renal cell, and colorectal carcinoma

Jan 1, 1986·Cancer Genetics and Cytogenetics·S Pathak, A Goodacre

Translocation breakpoint mapping: molecular and cytogenetic studies of chromosome 22

Jan 1, 1986·Cancer Genetics and Cytogenetics·B S EmanuelM A Israel

Molecular characteristics of chronic myelogenous leukemia in blast crisis

Aug 1, 1987·Cancer Genetics and Cytogenetics·M BlickJ U Gutterman

Two unusual complex translocations in Ph-positive chronic myeloid leukemia

Aug 1, 1987·Cancer Genetics and Cytogenetics·P H PinkertonJ S Senn

Utility of molecular genetic analysis of bcr rearrangement in the diagnosis of chronic myeloid leukemia

Nov 1, 1987·Cancer Genetics and Cytogenetics·P BennC Berger

Ph-positive chronic myeloid leukemia with near-haploid conversion in vivo and establishment of a continuously growing cell line with similar cytogenetic pattern

Feb 1, 1987·Cancer Genetics and Cytogenetics·B S AnderssonK B McCredie

Erythrocytosis and complex Ph translocation 46,XY,t(9;11;22) in a patient with chronic myelogenous leukemia

Feb 1, 1987·Cancer Genetics and Cytogenetics·K KubotaT Takeda

Cytogenetics and cell surface marker analysis in chronic myelocytic leukemia. II. Implications for patient management

May 1, 1987·Cancer Genetics and Cytogenetics·K E FuscaldoF S Ligler

Transposition of breakpoint cluster region (3' bcr) in CML cells with variant Philadelphia translocations

May 1, 1987·Cancer Genetics and Cytogenetics·K OhyashikiA A Sandberg

Philadelphia chromosome positive essential thrombocythemia evolving into lymphoid blast crisis

Apr 1, 1987·Cancer Genetics and Cytogenetics·E PaiettaP H Wiernik

Correlation between cytogenetic and molecular findings in human chronic myelogenous leukemia lines EM-2 and EM-3

Apr 1, 1987·Cancer Genetics and Cytogenetics·W H RaskindJ W Singer

A historical outline of the development of cancer cytogenetics

Sep 1, 1987·Cancer Genetics and Cytogenetics·T C Hsu

Variant Philadelphia translocations in CML: correlation with fragile sites

Mar 1, 1988·Cancer Genetics and Cytogenetics·M SessaregoF Ajmar

Molecular and clinical investigations in Philadelphia chromosome-negative chronic myelogenous leukemia

Jul 1, 1988·Cancer Genetics and Cytogenetics·J H OhyashikiK Toyama

Juvenile chronic myeloid leukemia: no rearrangement of the breakpoint cluster region

Dec 1, 1988·Cancer Genetics and Cytogenetics·H NakamuraK Toyama

Myelodysplastic syndrome with Philadelphia-like chromosome without bcr rearrangement

Oct 15, 1988·Cancer Genetics and Cytogenetics·J H OhyashikiK Toyama

A cytogenetic and molecular analysis of five variant Philadelphia translocations in chronic myeloid leukemia

Oct 15, 1988·Cancer Genetics and Cytogenetics·C MorrisP H Fitzgerald

The karyotype of Philadelphia chromosome-negative, bcr rearrangement-positive chronic myeloid leukemia

Oct 15, 1988·Cancer Genetics and Cytogenetics·M E WeinsteinS E Waintraub

The genomic breakpoint in a patient with Philadelphia-positive acute leukemia is 5' of the breakpoint cluster region

Jun 1, 1988·Cancer Genetics and Cytogenetics·F RassoolJ M Goldman

The Philadelphia chromosome. Considerations based on studies of variant Ph translocations

May 1, 1988·Cancer Genetics and Cytogenetics·T Ishihara, M Minamihisamatsu

A hypothesis regarding the development of acute myeloid leukemia from preleukemic disorders. The role of protooncogenes

May 1, 1988·Cancer Genetics and Cytogenetics·H D Preisler

The variable hematologic expression of the BCR-ABL genomic mutation and its possible determinants

Oct 1, 1989·Cancer Genetics and Cytogenetics·P H Fitzgerald, C Morris

Chromosome 22 breakpoints in variant Philadelphia translocations and Philadelphia-negative chronic myeloid leukemia

Feb 1, 1989·Cancer Genetics and Cytogenetics·P J BrowettJ D Norton

Cytogenetic and molecular studies in patients with chronic myeloid leukemia and variant Philadelphia translocations

Oct 15, 1989·Cancer Genetics and Cytogenetics·A ZaccariaS Tura

Studies of BCR and ABL gene rearrangements in chronic myelogenous leukemia patients by conventional and pulsed-field gel electrophoresis using gel inserts

Oct 15, 1989·Cancer Genetics and Cytogenetics·X Y JiangJ C Liang

Translocation t(9;9)(p13;q34) in Philadelphia-negative chronic myeloid leukemia with breakpoint cluster region rearrangement

Nov 1, 1989·Cancer Genetics and Cytogenetics·M SessaregoF Ajmar

Solid tumor cytogenetics. Progress since 1979

Jul 1, 1989·Cancer Genetics and Cytogenetics·N B Atkin

Chromosomal in situ hybridization and Southern blot analyses using c-abl, c-sis, or bcr probe in chronic myelogenous leukemia cells with variant Philadelphia translocations

Mar 1, 1989·Cancer Genetics and Cytogenetics·S AbeM Sasaki

Near-haploid cell line in megakaryoblastic transformation of Philadelphia-positive chronic myeloid leukemia

May 1, 1989·Cancer Genetics and Cytogenetics·K M Mayne, E J Maher

Chromosomal evolution in the progression and metastasis of human malignant melanoma. A multiple lesion study

Sep 1, 1989·Cancer Genetics and Cytogenetics·M I Pedersen, N Wang

Cytogenetic peculiarities in chronic myelogenous leukemia

Jul 15, 1990·Cancer Genetics and Cytogenetics·F Hild, C Fonatsch

Cytogenetic and molecular analysis of a "masked" Philadelphia chromosome in chronic and blastic phases of chronic myeloid leukemia

Jul 15, 1990·Cancer Genetics and Cytogenetics·H ZitzelsbergerP G Strauss

Philadelphia-positive acute leukemia. Cytogenetic and molecular aspects

Feb 1, 1990·Cancer Genetics and Cytogenetics·R BergerZ Chen

Chronic myeloid leukemia with unusual variant Ph translocation (22;22)(q11;q13). Two cases with chimeric BCR-ABL transcripts

Sep 1, 1990·Cancer Genetics and Cytogenetics·J L LaïM H Loucheux-Lefebvre

Philadelphia chromosome-positive chronic myelogenous leukemia in treated Hodgkin's disease

Oct 15, 1990·Cancer Genetics and Cytogenetics·G E G VerhoefM Boogaerts

bcr rearrangements in Philadelphia chromosome-positive acute lymphoblastic leukemia. A study of five Chinese patients in Taiwan

Jul 1, 1990·Cancer Genetics and Cytogenetics·M T LinK H Lin

Hodgkin's disease and secondary Philadelphia chromosome positive chronic myelogenous leukemia

Sep 1, 1991·Cancer Genetics and Cytogenetics·K BouabdallahP Bernard

Chromosomal characteristics of chronic and blastic phase of chronic myeloid leukemia. A study of 100 patients in India

Feb 1, 1991·Cancer Genetics and Cytogenetics·P R KadamT K Saikia

Pure red cell aplasia in a case of Ph negative BCR/ABL rearranged CML with t(12;14)(q23;p11)

Oct 15, 1991·Cancer Genetics and Cytogenetics·T LionO A Haas

Molecular differentiation of two different translocations producing two apparent Ph chromosomes in a patient with CML

Jul 15, 1991·Cancer Genetics and Cytogenetics·M E GonsebattL Pearce-Birge

Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML

Apr 1, 1991·Cancer Genetics and Cytogenetics·D C van der PlasA Hagemeijer

Trisomy 4 in a case of acute lymphocytic leukemia (L1)

Aug 1, 1992·Cancer Genetics and Cytogenetics·K HodoharaT Abe

Karyotype at relapse following allogeneic bone marrow transplantation for chronic myelogenous leukemia

Jul 15, 1992·Cancer Genetics and Cytogenetics·N K ShahC A Griffin

Restoration of cytogenetically normal marrow cells after remission of lymphoblastic crisis in a case of Ph positive CML treated with alpha-interferon

Feb 1, 1992·Cancer Genetics and Cytogenetics·K KawakuboK Toyama

Acute myelomonocytic leukemia with inv(16)(p13q22) complicating Philadelphia chromosome positive chronic myeloid leukemia

Mar 1, 1992·Cancer Genetics and Cytogenetics·S HeimN T Pedersen

Cytogenetic and molecular studies of the Philadelphia translocation in myelodysplastic syndromes. Report of two cases and review of the literature

Apr 1, 1992·Cancer Genetics and Cytogenetics·G E G VerhoefM Boogaerts

bcr breakpoint location in Spanish patients with chronic myelogenous leukemia

May 1, 1992·Cancer Genetics and Cytogenetics·A ValienteE Prieto

Microprocedure for in situ nick translation of chromosomes

Sep 1, 1992·Cancer Genetics and Cytogenetics·Z LiK Fan

A new chromosomal breakpoint in Ph positive, bcr negative chronic myelogenous leukemia. Report of a case

Jul 1, 1992·Cancer Genetics and Cytogenetics·M NegriniG L Castoldi

Remission of Philadelphia positive chronic myelogenous leukemia associated with t(3;21) after bone marrow transplantation

Jul 15, 1993·Cancer Genetics and Cytogenetics·M R UriarteH Cardoso

Blastic phase chronic myeloid leukemia with a four-break rearrangement: t(11;9)(9;22)(q23;p22q34;q11)

Jul 15, 1993·Cancer Genetics and Cytogenetics·L LiF Lampert

t(5;12)(q31;p12). A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia

Jan 1, 1993·Cancer Genetics and Cytogenetics·J W WesselsG C Beverstock

Deletion of chromosome 22 without bcr rearrangement and without juxtaposition of c-abl in a case of acute myeloid leukemia

Jun 1, 1993·Cancer Genetics and Cytogenetics·H XiaoS Kakati

Comparison of clinical and biologic features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia

Nov 1, 1993·Cancer Genetics and Cytogenetics·H J Ch'angK H Lin

Dual Alu polymerase chain reaction primers and conditions for isolation of human chromosome painting probes from hybrid cells

Feb 1, 1993·Cancer Genetics and Cytogenetics·P LiuM J Siciliano

Detection of variant Ph-positive chronic myelogenous leukemia involving chromosomes 1, 9, and 22 by fluorescence in situ hybridization

Feb 1, 1993·Cancer Genetics and Cytogenetics·D C SeongJ M Trujillo

Serendipity of Philadelphia chromosome

Jan 1, 1995·Cancer Genetics and Cytogenetics·R S Verma

Detection of M-bcr/abl fusion by fluorescence in situ hybridization (FISH) in a case of Ph negative CML

Mar 1, 1995·Cancer Genetics and Cytogenetics·A N MohamedS R Wolman

Translocation 11;14 in newly diagnosed chronic myelogenous leukemia

May 1, 1995·Cancer Genetics and Cytogenetics·A MagdalinskiD I Marks

Reversed BCR/ABL rearrangement detected by FISH in Philadelphia negative chronic myelocytic leukemia

Jun 1, 1995·Cancer Genetics and Cytogenetics·D AbeliovichD Ben-Yehuda

New translocations [t(6;15)(p25;q22) and t(6;19)(q16;q13.3)] with t(9;22)(q34;q11) in a Ph-positive chronic myelogenous leukemia

Jan 1, 1994·Cancer Genetics and Cytogenetics·M J MaceraR S Verma

Variant Philadelphia chromosome translocations are frequently associated with additional structural abnormalities

Mar 1, 1994·Cancer Genetics and Cytogenetics·M SessaregoF Patrone

Further evidence for the lack of correlation between the breakpoint site within M-BCR and CML prognosis and for the occasional involvement of p53 in transformation

Oct 15, 1995·Cancer Genetics and Cytogenetics·R C AguiarD Chamone

New variant Ph translocation in chronic myeloid leukemia: t(Y;22)(p11;q11)

Mar 1, 1996·Cancer Genetics and Cytogenetics·M S GallegoA Feliu

Persistence of AML1 rearrangement in peripheral blood cells in t(8;21)

Jun 1, 1996·Cancer Genetics and Cytogenetics·Y L KwongC H Chan

A Philadelphia chromosome positive CML patient with a unique translocation studied via GTG-banding and fluorescence in situ hybridization

Jul 15, 1996·Cancer Genetics and Cytogenetics·C YoungH F Mark

Environmental carcinogenesis and biotechnology

Oct 1, 1990·Journal of Biotechnology·M M Chu, A Chiu

The ABL oncogene in human leukemias

Mar 1, 1988·Blood Reviews·C A Westbrook

A structurally abnormal breakpoint cluster region gene in a transcription factor, hLH-2-negative human leukemia cell line

Jun 8, 1995·Cancer Letters·H K Wu

Clonal origin of human tumors

Oct 12, 1976·Biochimica Et Biophysica Acta·P J Fialkow

abl genes

Dec 17, 1989·Biochimica Et Biophysica Acta·L Ramakrishnan, N Rosenberg

The structure of mutation in mammalian cells

Jun 1, 1990·Biochimica Et Biophysica Acta·M Meuth

Molecular mechanisms in lung pathogenesis

Dec 10, 1991·Biochimica Et Biophysica Acta·D L Buchhagen

Diagnostic utility of oncogenes and their products in human cancer

Dec 10, 1991·Biochimica Et Biophysica Acta·S J McKenzie

Field alternation gel electrophoresis--status quo

Aug 25, 1993·Journal of Chromatography·K M Townsend, H J Dawkins

The last revised "Euro-American classification" of lymphoid leukemias and non-Hodgkin's lymphomas: the same inaccuracies and inconsistencies in a chaotic complexity

Jan 1, 1996·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·G Mathé

Comparison of baculovirus-expressed c-Abl and BCR/ABL protein tyrosine kinases

Apr 30, 1993·Biochimica Et Biophysica Acta·C H ReynoldsM J Page

Chronic myelogenous leukemia: an update on the biological findings and therapeutic approaches

Apr 1, 1996·Critical Reviews in Oncology/hematology·A FerrajoliF Grignani

Hematopoietic stem cells in chronic myeloid leukemia

Jan 22, 2004·Archives of Medical Research·Andreas Petzer, E Gunsilius

Use of new biotechnology to design rational drugs against newly defined targets

May 5, 2004·Best Practice & Research. Clinical Rheumatology·Jochen G Salfeld

Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening

Oct 14, 2003·Bioorganic & Medicinal Chemistry Letters·Hui PengChunzheng Yang

A complex translocation (9;22;16)(q34;q11.2;p13) in chronic myelocytic leukemia

Feb 22, 2005·Cancer Genetics and Cytogenetics·Juan Pablo Meza EspinozaJuan Ramón González García

Coexistence of different clonal populations harboring the b3a2 (p210) and e1a2 (p190) BCR-ABL1 fusion transcripts in chronic myelogenous leukemia resistant to imatinib

Jun 14, 2005·Cancer Genetics and Cytogenetics·Xabier AgirreMaría J Calasanz

A new recombinant immunotoxin hscFv-ETA' demonstrates specific cytotoxicity against chronic myeloid leukemia cells in vitro

Aug 21, 2013·Immunology Letters·Xiaoying ZhuWen-Li Feng

Comparison of M-FISH and conventional cytogenetic analysis in accelerated and acute phases of CML

Apr 28, 2004·Leukemia Research·Françoise BrizardAndré Brizard

Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia-retrospective study and review of literature

May 4, 2004·Leukemia Research·Yi-Kong KeungM J Pettenati

Philadelphia chromosome positive myelodysplastic syndrome and acute myelogenous leukemia

May 4, 2004·Leukemia Research·Anjali S Advani

Nuclear topography and expression of the BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA interference

Jun 28, 2005·Leukemia Research·E BártováS Kozubek

Mechanisms involved in the induced differentiation of leukemia cells

Dec 4, 2003·Pharmacology & Therapeutics·Asterios S TsiftsoglouIoannis S Vizirianakis

Targeted therapies in myeloid leukemia

Feb 6, 2004·Seminars in Cancer Biology·Alison M JohnRose Ann Padua

The role of DNA repair in the prevention of cancer

Jun 1, 1996·Molecular Aspects of Medicine·M Hall, R T Johnson

White cells 2: impact of understanding the molecular basis of haematological malignant disorders on clinical practice

May 3, 2000·Lancet·A K Stewart, A C Schuh

Selective transformation of B lymphocytes by E.B. virus

Jul 14, 1973·Lancet·P K PattengaleP Gerber

Letter: Acquired trisomies 12 and 7

Feb 16, 1974·Lancet·S KaffeK Hirschhorn

Brain cell chromosome translocation (2q;14q) associated with continuous partial epilepsy

Jun 26, 1982·Lancet·S CarpentierF Lhermitte

Oncogenes

Sep 1, 1983·CA: a Cancer Journal for Clinicians·R A Weinberg

Altered transcription of an oncogene in chronic myeloid leukaemia

Mar 17, 1984·Lancet·E CanaaniE Januszewicz

Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization

Mar 15, 2001·Leukemia Research·S NaumannH J Decker

Rapid clonal development in a relapsed CML 11 years post replete allogeneic bone marrow transplantation

Dec 6, 2001·Leukemia Research·P KearneyJ C Biggs

Runx1/AML1 in leukemia: disrupted association with diverse protein partners

Jan 17, 2002·Leukemia Research·Chava PerryHermona Soreq

The kinase inhibitor STI571 reverses the Bcr-Abl induced point mutation frequencies observed in pre-leukemic P190(Bcr-Abl) transgenic mice

Oct 5, 2002·Leukemia Research·Julia BrainPierre Laneuville

Enhanced uptake of antisense oligonucleotides using cationic liposomes and the apoptotic effect of idarubicin in K-562 cell line

May 15, 2002·Leukemia Research·Luciano VellónIrene Larripa

Bcr-Abl variants: biological and clinical aspects

Aug 23, 2002·Leukemia Research·Anjali S Advani, Ann Marie Pendergast

Elevated expression of a subset of interferon inducible genes in primary bone marrow cells expressing p185 Bcr-Abl versus p210 Bcr-Abl by DNA microarray analysis

Dec 23, 2003·Leukemia Research·Anjali S AdvaniAnn Marie Pendergast

Achievement of a complete cytogenetic response with hydroxyurea in a patient with chronic myelogenous leukemia

May 1, 1997·Leukemia Research·M TanakaM Utsumi

c-myc locus amplification and the acquisition of trisomy 8 in the evolution of chronic myeloid leukaemia

Oct 10, 1998·Leukemia Research·B A Jennings, K I Mills

Chronic myeloid leukemia with expression of ALL-type BCR/ABL transcript: a case-report and review of the literature

Sep 4, 1999·Leukemia Research·P SolvesM A Sanz Alonso

The influence of the cell cycle, differentiation and irradiation on the nuclear location of the abl, bcr and c-myc genes in human leukemic cells

Mar 30, 2000·Leukemia Research·E BártováK Buchnícková

Oligonucleotides as modulators of cancer gene expression

Jan 1, 1997·Pharmacology & Therapeutics·L D CurcioK J Scanlon

A simple strategy for breakpoint fragment determination in chronic myeloid leukemia

Dec 7, 2000·Cancer Genetics and Cytogenetics·A M KamelH S Moussa

Near haploid blast phase in a chronic myeloid leukemia detected by fluorescence in situ hybridization using a BCR-ABL probe

Aug 2, 2001·Cancer Genetics and Cytogenetics·D GancbergA Kornreich

Chronic myeloid leukemia with a rare variant Philadelphia translocation: t(9;10;22)(q34;q22;q11)

Aug 25, 2001·Cancer Genetics and Cytogenetics·W EmbergerK Wagner

Deletion of BCR region 3' in chronic myelogenous leukemia

Oct 24, 2001·Cancer Genetics and Cytogenetics·F A GonzálezA Villegas

Contribution of fluorescence in situ hybridization analyses to the characterization of masked and complex Philadelphia chromosome translocations in chronic myelocytic leukemia

Nov 19, 2003·Cancer Genetics and Cytogenetics·F MorelM De Braekeleer

A novel t(6;7)(p24;q21) in a chronic myelocytic leukemia in complete cytogenetic remission after therapy with imatinib mesylate

Jan 22, 2004·Cancer Genetics and Cytogenetics·Alessandro GozzettiFrancesco Lauria

Secondary chromosomal changes in 34 Philadelphia-chromosome-positive chronic myelocytic leukemia patients from the Mexican West

Jan 22, 2004·Cancer Genetics and Cytogenetics·Juan Pablo Meza EspinozaJuan Ramón González García

Constitutional chromosome aberrations as pathogenetic events in hematologic malignancies

Mar 24, 2004·Cancer Genetics and Cytogenetics·Jeanna Welborn

Characterization of a 14q+ marker chromosome in philadelphia chromosome positive acute lymphoblastic leukemia by DNA analysis and fluorescence in situ hybridization

May 1, 1995·Cancer Genetics and Cytogenetics·H NakaiKenji Kashima

Characterization of a complex translocation [t(4;9;22)(p16;q34;q11)] in chronic myelogenous leukemia by fluorescence in situ hybridization technique

Sep 1, 1996·Cancer Genetics and Cytogenetics·R GudiR S Verma

Molecular demonstration of BCR/ABL fusion in two cases with chronic myeloproliferative disorder carrying variant Philadelphia t(14;22)(q32;q11)

Oct 1, 1996·Cancer Genetics and Cytogenetics·M MantzouraniD Loukopoulos

Philadelphia chromosome in chronic myelogenous leukemia: confirmation of cytogenetic diagnosis in Ph positive and negative cases by fluorescence in situ hybridization

Apr 1, 1997·Cancer Genetics and Cytogenetics·H AcarM J Connor

Identification of variant translocations in chronic myeloid leukemia by fluorescence in situ hybridization

Feb 1, 1997·Cancer Genetics and Cytogenetics·H AcarM J Connor

Complex chromosome 4, 9, and 22 rearrangement in a patient presenting with AML-FAB M2

Feb 1, 1997·Cancer Genetics and Cytogenetics·Eric S MartinS E Martin

Occurrence of BCR-ABL rearrangement in a Philadelphia chromosome-negative patient with 5q and 13q deletions and myeloproliferative syndrome

Dec 24, 1997·Cancer Genetics and Cytogenetics·A VillegasC San Román

The Philadelphia chromosome as a secondary change in leukemia: three case reports and an overview of the literature

Mar 12, 1998·Cancer Genetics and Cytogenetics·Z ChenA A Sandberg

Extramedullary presentation of chronic myelogenous leukemia with p190 BCR/ABL transcripts

Apr 8, 1998·Cancer Genetics and Cytogenetics·H YamaguchiK Dan

Frequency of clonal B lymphocytes in chronic myelogenous leukemia evaluated by fluorescence in situ hybridization

Jul 2, 1998·Cancer Genetics and Cytogenetics·A al-AminO Kloke

Identification of BCR-ABL fusion on chromosome 9 by fluorescence in situ hybridization in two chronic myeloid leukemia cases

Sep 2, 1998·Cancer Genetics and Cytogenetics·Elisabetta AbruzzeseP N Rao

Fluorescence in situ hybridization studies of interphase nuclei for assessing response to therapy in patients with chronic myeloid leukemia

Nov 3, 1998·Cancer Genetics and Cytogenetics·Y KobzevGordon W Dewald

Simultaneous occurrence of chronic myelogenous leukemia and non-Hodgkin lymphoma at diagnosis

Feb 12, 1999·Cancer Genetics and Cytogenetics·H AcarA Acar

Comparative analysis of G-banding, chromosome painting, locus-specific fluorescence in situ hybridization, and comparative genomic hybridization in chronic myeloid leukemia blast crisis

May 18, 1999·Cancer Genetics and Cytogenetics·S M GribbleE P Nacheva

Fluorescence in situ hybridization analysis of complex translocations in two newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia patients

Oct 20, 1999·Cancer Genetics and Cytogenetics·E Rajcan-SeparovicH Wang

Instability of the Ph chromosome in chronic myelocytic leukemia: a case report

Nov 5, 1999·Cancer Genetics and Cytogenetics·Z ChenA A Sandberg

Translocation (5;9)(q22;q34) in a case of acute lymphoblastic leukemia with multiple bone involvement: effectiveness of donor lymphocyte infusion for relapse after allogeneic stem cell transplantation

Mar 8, 2000·Cancer Genetics and Cytogenetics·H TsujimuraT Takagi

New variant translocation (8;20)(q22;q13) in bone marrow cells of extramedullary blast crisis in chronic myelogenous leukemia

Mar 8, 2000·Cancer Genetics and Cytogenetics·Y HaradaT Hayashi

A FISH study of variant Philadelphia rearrangements

Apr 5, 2000·Cancer Genetics and Cytogenetics·K S Reddy, V Sulcova

Aneuploidy precedes and segregates with chemical carcinogenesis

Jun 27, 2000·Cancer Genetics and Cytogenetics·P DuesbergR Hehlmann

Allosterically controllable maxizymes cleave mRNA with high efficiency and specificity

Nov 4, 2000·Trends in Biotechnology·T KuwabaraK Taira

Numerical chromosome aberrations in hepatocellular carcinoma detected by fluorescence in situ hybridization

Nov 1, 1996·Journal of Hepatology·N OhsawaS Hirohashi

Molecular approaches to the detection and monitoring of chronic myeloid leukemia: theory and practice

Jul 22, 1999·Blood Reviews·K YeeArmand Keating

Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation

Jan 9, 2001·Experimental Hematology·R BhatiaM L Slovak

Novel therapies for chronic myelogenous leukemia

May 30, 2001·Experimental Hematology·B N JahagirdarC M Verfaillie

Contact with fibronectin enhances preservation of normal but not chronic myelogenous leukemia primitive hematopoietic progenitors

Apr 9, 2002·Experimental Hematology·R BhatiaH A Munthe

The emergence of Ph-, trisomy -8+ cells in patients with chronic myeloid leukemia treated with imatinib mesylate

Aug 7, 2003·Experimental Hematology·Eric FeldmanRichard T Silver

Role of abnormal integrin-cytoskeletal interactions in impaired beta1 integrin function in chronic myelogenous leukemia hematopoietic progenitors

Sep 10, 1999·Experimental Hematology·R BhatiaC M Verfaillie

Abl kinase but not PI3-kinase links to the cytoskeletal defects in Bcr-Abl transformed cells

Feb 5, 2000·Experimental Hematology·I GastonBrian J Druker

CrkL functions as a nuclear adaptor and transcriptional activator in Bcr-Abl-expressing cells

Mar 18, 2000·Experimental Hematology·J RhodesBrian J Druker

Detection of bcr/abl fusion transcripts by semiquantitative multiplex RT-PCR combined with a colormetric assay in Ph positive leukemia

Mar 21, 1998·Cancer Letters·H NiR Ueda

Bcr-Abl inhibition as a modality of CML therapeutics

Sep 13, 2001·Biochimica Et Biophysica Acta·E BuchdungerBrian J Druker

Applications of genetic technologies to cancer screening, prevention, diagnosis, prognosis, and treatment

May 1, 1997·Seminars in Oncology Nursing·J A Peters

ST1571: a paradigm for clinical trials of molecularly targeted agents

Jan 5, 2002·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Brian J Druker

Imatinib and chronic myeloid leukemia: validating the promise of molecularly targeted therapy

Jan 17, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Brian J Druker

Imatinib: the first 3 years

Comparison of the intrinsic kinase activity and substrate specificity of c-Abl and Bcr-Abl

Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·J J WuK S Lam

Chromosomal translocation t(14;18) in healthy individuals

Sep 10, 2003·Seminars in Cancer Biology·Frank SchülerGottfried Dölken

Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABL

Mar 1, 1997·Cytokine & Growth Factor Reviews·M Sattler, R Salgia

STI571 (Gleevec) as a paradigm for cancer therapy

Apr 3, 2002·Trends in Molecular Medicine·Brian J Druker

Quantitative intra-individual monitoring of BCR-ABL transcript levels in archival bone marrow trephines of patients with chronic myeloid leukemia

Jan 29, 2003·The Journal of Molecular Diagnostics : JMD·Oliver BockHans Kreipe

Clinical applications of BCR-ABL molecular testing in acute leukemia

Apr 23, 2003·The Journal of Molecular Diagnostics : JMD·Amgad L NashedMargaret L Gulley

Chronic myeloid leukemia: a minimalistic view of post-therapeutic monitoring

Feb 5, 2002·The Journal of Molecular Diagnostics : JMD·Adam Bagg

Bestatin selectively suppresses the growth of leukemic stem/progenitor cells with BCR/ABL mRNA transcript in patients with chronic myelogeneous leukemia

Jun 5, 2003·International Immunopharmacology·Tomoaki FujisakiFuminori Abe

Distribution of human chromosomes on the metaphase plate. Symmetrical arrangement in human male cells

Dec 1, 1980·Genetical Research·M D CollJ Egozcue

Computational analysis of the binding specificity of Gleevec to Abl, c-Kit, Lck, and c-Src tyrosine kinases

Sep 5, 2013·Journal of the American Chemical Society·Yen-Lin Lin, Benoît Roux

Improved coiled-coil design enhances interaction with Bcr-Abl and induces apoptosis

Dec 6, 2011·Molecular Pharmaceutics·Andrew S DixonCarol S Lim

Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferation

Dec 6, 2012·Molecular Pharmaceutics·David W Woessner, Carol S Lim

Global proteome quantification for discovering imatinib-induced perturbation of multiple biological pathways in K562 human chronic myeloid leukemia cells

Oct 19, 2010·Journal of Proteome Research·Lei XiongYinsheng Wang

Cancer genetics, cytogenetics--defining the enemy within

Oct 15, 1998·Nature Medicine·Peter C NowellA G Knudson

Comparable complex rearrangements involving 8;21 and 9;22 translocations in leukaemia

Apr 21, 1977·Nature·V Lindgren, Janet D Rowley

Further phenotypic characterization of the primitive lineage- CD34+CD38-CD90+CD45RA- hematopoietic stem cell/progenitor cell sub-population isolated from cord blood, mobilized peripheral blood and patients with chronic myelogenous leukemia

Jul 26, 2012·Blood Cancer Journal·D WisniewskiBayard Clarkson

BUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD)

Jan 9, 2010·Cell Death and Differentiation·Y NiikuraK Kitagawa

Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells

Jul 30, 2008·Cell Research·Xin MaoWen Xin Li

The Ashton Lecture. Uveal melanoma: the past, the present and the future

Jan 1, 1997·Eye·I G Rennie

Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders

Jun 6, 2008·Leukemia·C WalzAndreas Reiter

Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs)

Aug 30, 2008·Leukemia·J T Reilly

Choosing the best treatment strategy for chronic myeloid leukemia patients resistant to imatinib: weighing the efficacy and safety of individual drugs with BCR-ABL mutations and patient history

Oct 3, 2009·Leukemia·Elias JabbourHagop M Kantarjian

Blocking cytokine signaling along with intense Bcr-Abl kinase inhibition induces apoptosis in primary CML progenitors

Feb 5, 2010·Leukemia·Devendra K HiwaseT Hughes

Bcr-Abl-mediated redox regulation of the PI3K/AKT pathway

Mar 20, 2009·Leukemia·R NaughtonThomas G Cotter

BCR-ABL promotes neutrophil differentiation in the chronic phase of chronic myeloid leukemia by downregulating c-Jun expression

Apr 10, 2009·Leukemia·S KobayashiK Motoyoshi

Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity

Apr 17, 2009·Leukemia·W KernS Schnittger

BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients

Jun 4, 2010·Leukemia·M MaregaCarlo Gambacorti-Passerini

Insights into the stem cells of chronic myeloid leukemia

Sep 24, 2010·Leukemia·I SlomaC J Eaves

Inhibition of Grb2 expression demonstrates an important role in BCR-ABL-mediated MAPK activation and transformation of primary human hematopoietic cells

Nov 13, 2010·Leukemia·Hardik ModiR Bhatia

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression

Apr 23, 2010·Leukemia·J BoultwoodJ S Wainscoat

The controversial role of the Hedgehog pathway in normal and malignant hematopoiesis

Jun 11, 2011·Leukemia·B G MarS Buonamici

The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem/progenitor cells

Apr 13, 2011·Leukemia·Francesca PellicanoTessa L Holyoake

Re-emergence of interferon-α in the treatment of chronic myeloid leukemia

Dec 15, 2012·Leukemia·Moshe TalpazJorge Cortes

Cleavage of BCR-ABL transcripts at the T315I point mutation by DNAzyme promotes apoptotic cell death in imatinib-resistant BCR-ABL leukemic cells

Feb 26, 2013·Leukemia·J E KimD-E Kim

PML targeting eradicates quiescent leukaemia-initiating cells

May 13, 2008·Nature·Keisuke ItoPier Paolo Pandolfi

The cancer genome

Apr 11, 2009·Nature·Michael R StrattonP Andrew Futreal

The mutation spectrum revealed by paired genome sequences from a lung cancer patient

May 28, 2010·Nature·William LeeZemin Zhang

A continuum model for tumour suppression

Aug 13, 2011·Nature·Alice H BergerPier Paolo Pandolfi

The last shall be first

Feb 1, 1993·Nature Genetics·J M Trent, P S Meltzer

Breaking the rules of cancer

Jan 7, 2006·Nature Medicine·David R Shaffer, Pier Paolo Pandolfi

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

May 1, 1996·Nature Medicine·Brian J DrukerN B Lydon

Treating cancer's kinase 'addiction'

Aug 3, 2004·Nature Medicine·José Baselga, Joaquín Arribas

Attacking cancer at its foundation

Oct 9, 2009·Nature Medicine·N B Lydon

Shifting paradigms: the seeds of oncogene addiction

Oct 9, 2009·Nature Medicine·Charles L Sawyers

Cytogenetic harvesting of commonly used tumor cell lines

Apr 5, 2007·Nature Protocols·Roderick A F MacLeodHans G Drexler

The impact of translocations and gene fusions on cancer causation

Mar 16, 2007·Nature Reviews. Cancer·F MitelmanFredrik Mertens

Chronic myeloid leukaemia as a model of disease evolution in human cancer

May 25, 2007·Nature Reviews. Cancer·J V Melo, David J Barnes

Recurrent gene fusions in prostate cancer

Jun 20, 2008·Nature Reviews. Cancer·Chandan Kumar-SinhaArul M Chinnaiyan

Apoptosis and cancer: the genesis of a research field

Jun 25, 2009·Nature Reviews. Cancer·Thomas G Cotter

Leukaemogenesis: more than mutant genes

Dec 24, 2009·Nature Reviews. Cancer·Jianjun ChenJanet D Rowley

Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics

Oct 7, 2009·Nature Reviews. Clinical Oncology·Ayalew TefferiJames W Vardiman

What are we learning from the cancer genome?

Sep 12, 2012·Nature Reviews. Clinical Oncology·Eric A CollissonJoe W Gray

A robustness-based approach to systems-oriented drug design

Feb 24, 2007·Nature Reviews. Drug Discovery·Hiroaki Kitano

The secret ally: immunostimulation by anticancer drugs

Feb 4, 2012·Nature Reviews. Drug Discovery·Lorenzo GalluzziGuido Kroemer

The chromosome number in humans: a brief history

Jul 19, 2006·Nature Reviews. Genetics·Stanley M Gartler

An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259

Sep 17, 2008·Oncogene·T Pene-DumitrescuT E Smithgall

A non-Smad mechanism of fibroblast activation by transforming growth factor-beta via c-Abl and Egr-1: selective modulation by imatinib mesylate

Jan 20, 2009·Oncogene·Swati BhattacharyyaJohn Varga

The human Rgr oncogene is overexpressed in T-cell malignancies and induces transformation by acting as a GEF for Ras and Ral

Mar 29, 2011·Oncogene·K Osei-SarfoA Pellicer

Targeting abnormal DNA double-strand break repair in tyrosine kinase inhibitor-resistant chronic myeloid leukemias

May 30, 2012·Oncogene·L A TobinF V Rassool

Nonproliferating CML CD34+ progenitors are resistant to apoptosis induced by a wide range of proapoptotic stimuli

Apr 9, 2005·Leukemia·M S HoltzR Bhatia

Compensatory PI3-kinase/Akt/mTor activation regulates imatinib resistance development

Sep 2, 2005·Leukemia·A BurchertA Neubauer

Dual tyrosine kinase inhibitors in chronic myeloid leukemia

Sep 24, 2005·Leukemia·Giovanni MartinelliMichele Baccarani

Fusion tyrosine kinase mediated signalling pathways in the transformation of haematopoietic cells

Feb 17, 2006·Leukemia·S D Turner, D R Alexander

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia

Feb 25, 2006·Leukemia·L CampbellJ Boultwood

BCR-ABL activity and its response to drugs can be determined in CD34+ CML stem cells by CrkL phosphorylation status using flow cytometry

Mar 31, 2006·Leukemia·Ashley HamiltonTessa L Holyoake

A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translation

Aug 29, 2006·Oncogene·S PrabhuS T Ong

MicroRNAs and chromosomal abnormalities in cancer cells

Oct 10, 2006·Oncogene·George A Calin, Carlo M Croce

Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice

Jan 15, 2008·Oncogene·T MizunoHiroaki Honda

Microfluidic single cell arrays to interrogate signalling dynamics of individual, patient-derived hematopoietic stem cells

Aug 26, 2009·Lab on a Chip·Shannon L FaleyJonathan M Cooper

Exon-skipping in BCR/ABL is induced by ABL exon 2

May 5, 2000·The Biochemical Journal·B D Lichty, S Kamel-Reid

Chronic myelogenous leukaemia CD34+ cells exit G0/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells

Aug 29, 1998·British Journal of Haematology·C M TraycoffK Cornetta

Expression of p210 and p190 BCR-ABL due to alternative splicing in chronic myelogenous leukaemia

Dec 19, 1998·British Journal of Haematology·B D LichtyS Kamel-Reid

Normal primitive haemopoietic progenitors are more frequent than their leukaemic counterpart in newly diagnosed patients with chronic myeloid leukaemia but rapidly decline with time

Mar 23, 1999·British Journal of Haematology·F FrassoniM Cazzola

Chronic myelogenous leukaemia with p185(BCR/ABL) expression: characteristics and clinical significance

Dec 3, 1999·British Journal of Haematology·F RavandiHagop M Kantarjian

The story of chronic myeloid leukaemia

Aug 10, 2000·British Journal of Haematology·C G Geary

Deletion of the 5'-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients

Aug 10, 2000·British Journal of Haematology·C HerensL Koulischer

Chronic myelogenous leukaemia

Feb 13, 2001·British Journal of Haematology·S J Lee

Recent advances in the molecular and cellular biology of chronic myeloid leukaemia: lessons to be learned from the laboratory

May 1, 2001·British Journal of Haematology·D T Holyoake

Variant Philadelphia translocations in chronic myeloid leukaemia can mimic typical blast crisis chromosome abnormalities or classic t(9;22): a report of two cases

Jun 14, 2001·British Journal of Haematology·Alistair G ReidE P Nacheva

p53 expression in K562 cells is associated with caspase-mediated cleavage of c-ABL and BCR-ABL protein kinases

May 25, 2002·British Journal of Haematology·Alessandra M A Di Bacco, Thomas G Cotter

Myeloid/natural killer cell precursor acute leukaemia with minor bcr/abl mRNA transcript

Jul 26, 2002·British Journal of Haematology·Junji IkewakiMasaru Nasu

STI-571 in chronic myelogenous leukaemia

Oct 3, 2002·British Journal of Haematology·Anne S TsaoMoshe Talpaz

Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?

Dec 21, 2000·Histopathology·J D PfeiferL P Dehner

Chronic myelogenous leukaemia--new therapeutic principles

Jul 17, 2001·Journal of Internal Medicine·M E O'Dwyer, Brian J Druker

Small molecule: large hopes

Oct 5, 2001·Internal Medicine Journal·J Szer, G J Lieschke

Molecular mechanisms of transformation by the BCR-ABL oncogene

Jun 5, 2003·Seminars in Hematology·Martin Sattler, J D Griffin

Prediction of response to imatinib by cDNA microarray analysis

Jun 5, 2003·Seminars in Hematology·Ryuzo Ohno, Yusuke Nakamura

Cytogenetics of clonal growths

Aug 9, 1973·The New England Journal of Medicine·J Lejeune

The origin and development of human tumors studied with cell markers

Jul 4, 1974·The New England Journal of Medicine·P J Fialkow

Letter: Philadelphia chromosome (Ph1) translocation in an apparently Ph1 negative, minus G22, case of chronic myeloid leukemia

Jul 18, 1974·The New England Journal of Medicine·E EngelB J Myers

Letter: Translocation of the Philadelphia chromosome onto the 17 short arm in chronic myeloid leukemia: a second example

Sep 25, 1975·The New England Journal of Medicine·E EngleS B Krantz

Philadelphia chromosome with t(6;22) (p25;q12)

Apr 8, 1976·The New England Journal of Medicine·Z MammonH Joshua

Letter: Another variant translocation in chronic myelogenous leukemia--revisited

Oct 14, 1976·The New England Journal of Medicine·Janet D RowleyA A Horland

Chronic myelogenous leukemia with an unusual karyotype: 46,XY,t(17q +; 22q-)

Dec 30, 1976·The New England Journal of Medicine·M MatsunagaM Ichimaru

Chromosome banding patterns of 49 cases of chronic myelocytic leukemia

Jun 2, 1977·The New England Journal of Medicine·E EngelS B Krantz

Origin of chronic myelocytic leukemia in a precursor of pre-B lymphocytes

Jul 19, 1979·The New England Journal of Medicine·T W LeBienJ H Kersey

Chronic myelogenous leukemia--new concepts (first of two parts)

May 14, 1981·The New England Journal of Medicine·H P Koeffler, D W Golde

Distinguishing the Philadelphia chromosome of acute lymphoblastic leukemia from its counterpart in chronic myelogenous leukemia

Jul 4, 1985·The New England Journal of Medicine·S RodenhuisA J Veerman

Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome

Dec 5, 1985·The New England Journal of Medicine·K StamJ Groffen

Clinical implications of tumor-cell heterogeneity

May 29, 1986·The New England Journal of Medicine·L Schnipper

Blast crisis--reversing the direction

Dec 4, 1986·The New England Journal of Medicine·J F Desforges, K B Miller

The molecular genetics of Philadelphia chromosome-positive leukemias

Oct 13, 1988·The New England Journal of Medicine·R KurzrockMoshe Talpaz

The molecular basis of leukemia

Feb 3, 1994·The New England Journal of Medicine·M J Cline

Spontaneous remission in a patient with chronic myelogenous leukemia

Jan 30, 1997·The New England Journal of Medicine·M MusashiT Miyazaki

Chronic myeloid leukemia

Apr 29, 1999·The New England Journal of Medicine·Charles L Sawyers

The biology of chronic myeloid leukemia

Jul 15, 1999·The New England Journal of Medicine·S FaderlHagop M Kantarjian

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

Apr 5, 2001·The New England Journal of Medicine·Brian J DrukerCharles L Sawyers

BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia

Jul 20, 2007·The New England Journal of Medicine·Charles Schiffer

Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia

Mar 1, 2002·The New England Journal of Medicine·Hagop M KantarjianInternational STI571 CML Study Group

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

Mar 15, 2003·The New England Journal of Medicine·Stephen G O'BrienIRIS Investigators

Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML

Aug 13, 2004·The New England Journal of Medicine·Catriona H M JamiesonIrving L Weissman

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

Dec 8, 2006·The New England Journal of Medicine·Brian J DrukerIRIS Investigators

Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia

Dec 24, 2010·The New England Journal of Medicine·Claude PreudhommeFrance Intergroupe des Leucémies Myéloïdes Chroniques (Fi-LMC)

Imatinib mesylate--a new oral targeted therapy

Mar 1, 2002·The New England Journal of Medicine·David G Savage, Karen H Antman

Chronic myeloid leukemia--advances in biology and new approaches to treatment

Oct 10, 2003·The New England Journal of Medicine·John M Goldman, J V Melo

Chromosomal abnormalities in cancer

Aug 16, 2008·The New England Journal of Medicine·Stefan Fröhling, Hartmut Döhner

Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein

Sep 2, 2010·Proceedings of the National Academy of Sciences of the United States of America·Marcus JäråsThoas Fioretos

ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia

Jan 1, 2013·Proceedings of the National Academy of Sciences of the United States of America·Qingfei JiangCatriona H M Jamieson

Explaining why Gleevec is a specific and potent inhibitor of Abl kinase

Jan 16, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yen-Lin LinBenoît Roux

A general theory of carcinogenesis

Dec 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·D E Comings

Nonrandom chromosomal abnormalities in hematologic disorders of man

Jan 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·Janet D Rowley

Trisomy of chromosome 15 in spontaneous leukemia of AKR mice

Apr 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·R DofukuL J Old

Somatic rearrangement of chromosome 14 in human lymphocytes

Jun 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·B K McCawR L Teplitz

Chromosome mapping of the genes that control differentiation and malignancy in myeloid leukemic cells

Jan 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·J I Azumi, L Sachs

Measurement of mutagenesis in mammalian cells

Mar 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·C WaldrenT T Puck

Gene-amplification model of carcinogenesis

Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·M L Pall

Chromosomal assignment of the human homologues of feline sarcoma virus and avian myeloblastosis virus onc genes

Aug 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R Dalla-FaveraC M Croce

DNA sequence associated with chromosome translocations in mouse plasmacytomas

Nov 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·L J HarrisK B Marcu

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R Dalla-FaveraC M Croce

Construction and characterization of genomic libraries from specific human chromosomes

May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R KrumlaufB D Young

Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562

Aug 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·S J Collins, M T Groudine

Amplified C lambda and c-abl genes are on the same marker chromosome in K562 leukemia cells

Dec 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·J R SeldenC M Croce

Structural organization and expression of human DNA sequences related to the transforming gene of avian myeloblastosis virus

Dec 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·G FranchiniS R Tronick

An 8-kilobase abl RNA transcript in chronic myelogenous leukemia

Sep 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·R P Gale, E Canaani

Chromosomal localization and characterization of c-abl in the t(6;9) of acute nonlymphocytic leukemia

Dec 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C A WestbrookJanet D Rowley

Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration

Mar 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·J B KonopkaO N Witte

Restriction fragment length polymorphism caused by a deletion within the human c-abl gene (ABL)

May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·D Q Xu, F Galibert

Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients

Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J B KonopkaO N Witte

Comparison of constitutional and tumor-associated 11;22 translocations: nonidentical breakpoints on chromosomes 11 and 22

Aug 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·C A GriffinB S Emanuel

The human c-ros gene (ROS) is located at chromosome region 6q16----6q22

Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·L NagarajanC M Croce

Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome

Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A M Mes-MassonO N Witte

Heterogeneity of chromosome 22 breakpoint in Philadelphia-positive (Ph+) acute lymphocytic leukemia

Mar 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·J EriksonC M Croce

v-abl activates embryonic globin gene expression in mouse erythroleukemia cells

Apr 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·A R LopezA Deisseroth

DNA segment containing C beta 1, a gene for the constant region of the beta chain of the T-cell antigen receptor, was inserted into chromosome 6 in cells from one patient with human T-cell leukemia

Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·T InoM Hirano

Cell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residues

Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·R D HuhnA R Frackelton

Intracellular growth factors in polycythemia vera and other myeloproliferative disorders

Jan 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·J EidJ L Spivak

Mapping of four distinct BCR-related loci to chromosome region 22q11: order of BCR loci relative to chronic myelogenous leukemia and acute lymphoblastic leukemia breakpoints

Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·C M CroceE Canaani

Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro

Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·E S KawasakiF P McCormick

Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein

Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G Q Daley, D Baltimore

Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia

Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C M RubinC A Westbrook

Localization of preferential sites of rearrangement within the BCR gene in Philadelphia chromosome-positive acute lymphoblastic leukemia

Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·C T DennyO N Witte

Unexpected heterogeneity of BCR-ABL fusion mRNA detected by polymerase chain reaction in Philadelphia chromosome-positive acute lymphoblastic leukemia

Jun 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A L HoobermanC A Westbrook

Alterations in the p53 gene and the clonal evolution of the blast crisis of chronic myelocytic leukemia

Sep 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·H AhujaM J Cline

Molecular relapse in chronic myelogenous leukemia patients after bone marrow transplantation detected by polymerase chain reaction

Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·Charles L SawyersR Champlin

p53 in chronic myelogenous leukemia in acute phase

Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·E FeinsteinE Canaani

Blast crisis in a murine model of chronic myelogenous leukemia

Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·G Q DaleyD Baltimore

Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice

Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M L GishizkyO N Witte

The rho-specific guanine nucleotide exchange factor Dbs regulates breast cancer cell migration

Apr 16, 2009·The Journal of Biological Chemistry·Zhuoming LiuIan P Whitehead

Identification and selected reaction monitoring (SRM) quantification of endocytosis factors associated with Numb

Dec 6, 2012·Molecular & Cellular Proteomics : MCP·Jonathan R KriegerC Jane McGlade

bcr Rearrangement without juxtaposition of c-abl in chronic myelocytic leukemia

Dec 1, 1985·The Journal of Experimental Medicine·C R Bartram

Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis

Nov 1, 1986·The Journal of Experimental Medicine·C R BartramG Grosveld

Antibody recognition of the tumor-specific bcr-abl joining region in chronic myeloid leukemia

Jan 1, 1989·The Journal of Experimental Medicine·J van DenderenW van Ewijk

Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway

Jan 1, 1994·The Journal of Experimental Medicine·T TauchiHal E Broxmeyer

The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells

Mar 3, 2004·The Journal of Experimental Medicine·Florian KleinMarkus Müschen

13cis- and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatment in vitro

Oct 18, 2001·Cancer Biotherapy & Radiopharmaceuticals·M BenthinJ Atzpodien

Specific killing of Ph+ chronic myeloid leukemia cells by a lentiviral vector-delivered anti-bcr/abl small hairpin RNA

Mar 6, 2004·Oligonucleotides·Ming-Jie LiJohn J Rossi

Genome-wide identification of genes required for yeast growth under imatinib stress: vacuolar H+-ATPase function is an important target of this anticancer drug

Mar 6, 2009·Omics : a Journal of Integrative Biology·Sandra C dos Santos, Isabel Sá-Correia

The role of natural killer cells in the treatment of chronic myeloid leukemia

Aug 1, 1995·Journal of Hematotherapy·L M SillaE D Ball

Cancer cytogenetics in the zebrafish

Nov 18, 2009·Zebrafish·Samuel M Peterson, Jennifer L Freeman

Using Bcr-Abl to examine mechanisms by which abl kinase regulates morphogenesis in Drosophila

Oct 26, 2007·Molecular Biology of the Cell·Traci L StevensMark Peifer

Genomics and epigenomics: new promises of personalized medicine for cancer patients

Jul 3, 2013·Briefings in Functional Genomics·Michal-Ruth SchweigerBernd Timmermann

Comrad: detection of expressed rearrangements by integrated analysis of RNA-Seq and low coverage genome sequence data

Apr 12, 2011·Bioinformatics·Andrew McPhersonS Cenk Sahinalp

Identification of cancer fusion drivers using network fusion centrality

Mar 19, 2013·Bioinformatics·Chia-Chin WuAleksandar Milosavljevic

Human leukemic cell lines synthesize hyaluronan to avoid senescence and resist chemotherapy

Sep 10, 2013·Glycobiology·Silvina Laura LompardíaSilvia Elvira Hajos

Sustained superior long-term outcomes and cytogenetic responses with imatinib mesylate in chronic phase chronic myeloid leukaemia: report from a developing country

Mar 2, 2010·Japanese Journal of Clinical Oncology·Zeba AzizMuhammad Akram

A Bcr/Abl kinase antagonist for chronic myelogenous leukemia: a promising path for progress emerges

Jan 29, 1999·Journal of the National Cancer Institute·E A Sausville

Megakaryocytic differentiation in human chronic myelogenous leukemia K562 cells induced by ionizing radiation in combination with phorbol 12-myristate 13-acetate

Dec 25, 2012·Journal of Radiation Research·Katsumi HiroseIkuo Kashiwakura

The isolation of a human Ig V lambda gene from a recombinant library of chromosome 22 and estimation of its copy number

Sep 11, 1984·Nucleic Acids Research·M L AndersonB D Young

Regional mapping of two human immunoglobulin V lambda genes and analysis of the V lambda locus in chronic myeloid leukaemia

Aug 26, 1985·Nucleic Acids Research·M L AndersonB D Young

Molecular analysis of both translocation products of a Philadelphia-positive CML patient

Sep 11, 1986·Nucleic Acids Research·A de KleinG Grosveld

Duplication of the bcr and gamma-glutamyl transpeptidase genes

Aug 25, 1988·Nucleic Acids Research·N Heisterkamp, J Groffen

The first BCR gene intron contains breakpoints in Philadelphia chromosome positive leukemia

Nov 11, 1988·Nucleic Acids Research·N HeisterkampJ Groffen

Nucleotide sequence of both reciprocal translocation junction regions in a patient with Ph positive acute lymphoblastic leukaemia, with a breakpoint within the first intron of the BCR gene

Jan 11, 1989·Nucleic Acids Research·M J van der FeltzL M Wiedemann

ABR, an active BCR-related gene

Nov 11, 1989·Nucleic Acids Research·N HeisterkampJ Groffen

Selective cleavage of bcr-abl chimeric RNAs by a ribozyme targeted to non-contiguous sequences

Feb 11, 1994·Nucleic Acids Research·C J PachukL R Coney

Comparison of the specificities and catalytic activities of hammerhead ribozymes and DNA enzymes with respect to the cleavage of BCR-ABL chimeric L6 (b2a2) mRNA

Aug 1, 1997·Nucleic Acids Research·T KuwabaraK Taira

Modification of the methylation pattern in the vicinity of the chicken globin genes in avian erythroblastosis virus transformed cells

Apr 24, 1981·Nucleic Acids Research·L MarcaudK Scherrer

Targeted next-generation sequencing of DNA regions proximal to a conserved GXGXXG signaling motif enables systematic discovery of tyrosine kinase fusions in cancer

Jul 1, 2010·Nucleic Acids Research·Juliann ChmieleckiWilliam Pao

How does DNA break during chromosomal translocations?

Apr 19, 2011·Nucleic Acids Research·Mridula Nambiar, Sathees C Raghavan

De novo production of diverse intracellular antibody libraries

Feb 22, 2003·Nucleic Acids Research·Tomoyuki TanakaTerence H Rabbitts

Status of bcr-abl tyrosine kinase inhibitors in chronic myelogenous leukemia

Nov 21, 2000·Current Opinion in Oncology·M E O'Dwyer, Brian J Druker

Chronic myelogenous leukemia

Jan 10, 2001·Current Opinion in Oncology·Michael J Mauro, Brian J Druker

Smenospongine, a spongean sesquiterpene aminoquinone, induces erythroid differentiation in K562 cells

Apr 2, 2004·Anti-cancer Drugs·Shunji AokiMotomasa Kobayashi

Leukemias

Oct 9, 2002·Clinical Obstetrics and Gynecology·Tanja Pejovic, Peter E Schwartz

Acute Philadelphia chromosome-positive leukemia in an adolescent boy after liver transplantation

Jul 9, 2003·Journal of Pediatric Hematology/oncology·Christopher C SillimanLoris McGavran

Advances in immunotherapy of hematologic malignancies: cellular and humoral approaches

Jul 6, 2000·Current Opinion in Hematology·J G JurcicD A Scheinberg

Genomic approaches to the pathogenesis and treatment of acute lymphoblastic leukemias

Jun 4, 2002·Current Opinion in Hematology·Scott A ArmstrongStanley J Korsmeyer

Long-term cytogenetic remission with ubenimex monotherapy in a case of chronic myeloid leukemia

Jul 23, 2004·Anti-cancer Drugs·Heiwa KanamoriYoshiaki Ishigatsubo

Cytogenetics and the evolution of medical genetics

Jul 22, 2008·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Malcolm A Ferguson-Smith

Development of an effective therapy for chronic myelogenous leukemia

Dec 14, 2011·The Cancer Journal·David W WoessnerMichael W Deininger

On the dynamics of neutral mutations in a mathematical model for a homogeneous stem cell population

Dec 12, 2012·Journal of the Royal Society, Interface·Arne TraulsenDavid Dingli

Failure of CDKN2A/B (INK4A/B-ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL

Jun 4, 2008·Genes & Development·Charles G MullighanCharles J Sherr

Integrative analysis of the melanoma transcriptome

Feb 25, 2010·Genome Research·Michael F BergerLevi A Garraway

Expression of angiogenic factors in chronic myeloid leukaemia: role of the bcr/abl oncogene, biochemical mechanisms, and potential clinical implications

Aug 5, 2004·European Journal of Clinical Investigation·Christian SillaberPeter Valent

Trisomy-9 in the bone marrow of a patient with acute myelomonoblastic leukaemia

Mar 1, 1974·British Journal of Haematology·F J RuttenD J Wagener

Philadelphia-chromosome positive bone-marrow cells showing loss of the Y in males with chronic myeloid leukaemia

Jun 1, 1974·British Journal of Haematology·S D LawlerE Wiltshaw

Chromosomes in haematology

Aug 1, 1977·British Journal of Haematology·S D Lawler

The pathogenesis of myeloproliferative syndromes

Mar 1, 1978·British Journal of Haematology·J W Adamson, P J Fialkow

Immunological diagnosis of leukaemia and lymphoma: a World Health Organization/International Union of Immunological Societies technical report

Jan 1, 1978·British Journal of Haematology

Molecular analysis of chromosome 22 breakpoints in adult Philadelphia-positive acute lymphoblastic leukaemia

Sep 1, 1987·British Journal of Haematology·R KurzrockMoshe Talpaz

Chromosome and bcr rearrangement in chronic myelogenous leukaemia and their correlation with clinical states and prognosis of the disease

Aug 1, 1990·British Journal of Haematology·H F TienC H Liu

The role of alternative splicing patterns of BCR/ABL transcripts in the generation of the blast crisis of chronic myeloid leukaemia

Sep 1, 1990·British Journal of Haematology·G J MorganL M Wiedemann

ABL proteins in Philadelphia-positive acute leukaemias and chronic myelogenous leukaemia blast crises

Sep 1, 1990·British Journal of Haematology·C PonzettoM L Abate

Philadelphia chromosome positive B-cell type malignant lymphoma expressing an aberrant 190 kDa bcr-abl protein

Oct 1, 1990·British Journal of Haematology·K MitaniF Takaku

Immunophenotypic, genomic and clinical characteristics of blast crisis of chronic myelogenous leukaemia

Nov 1, 1991·British Journal of Haematology·J M HernándezA López-Borrasca

The molecular pathology of chronic myelogenous leukaemia

Oct 1, 1991·British Journal of Haematology·R Kurzrock, Moshe Talpaz

The clinical application of molecular techniques in Philadelphia-positive leukaemia

Jan 1, 1992·British Journal of Haematology·G J Morgan, L M Wiedemann

Simultaneous establishment of myeloid and B-lymphoid cell lines with identical chromosome abnormalities from Philadelphia chromosome-positive chronic myelogenous leukaemia

Nov 1, 1992·British Journal of Haematology·M YasukawaS Fujita

Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy

Dec 1, 1992·British Journal of Haematology·M C MalingeB Grandchamp

Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation

Dec 1, 1992·British Journal of Haematology·M LeeS Stass

The type of BCR/ABL junction does not predict the survival of patients with Ph1-positive chronic myeloid leukaemia

Jun 1, 1993·British Journal of Haematology·A ZaccariaA Ambrosetti

Consistent involvement of the 3' half part of the first BCR intron in adult Philadelphia-positive leukaemia without M-bcr rearrangement

Jan 1, 1993·British Journal of Haematology·Y NakamuraN Aoki

Minor myeloid component in Ph chromosome-positive acute lymphoblastic leukaemia: correlation with cytogenetic pattern and implication for poor response to therapy

Jul 1, 1994·British Journal of Haematology·Antonio CuneoM G Carli

Lymphoid blast crisis at the onset of chronic myelogenous leukaemia: molecular evidence

Jul 1, 1994·British Journal of Haematology·J RomanA Torres

Philadelphia chromosome-negative chronic myeloid leukaemia: a report of 14 new cases

Jun 1, 1995·British Journal of Haematology·R CostelloD Maraninchi

Apoptosis in chronic myeloid leukaemia: normal responses by progenitor cells to growth factor deprivation, X-irradiation and glucocorticoids

Oct 1, 1995·British Journal of Haematology·T A AmosM Y Gordon

Characterization of T-cell receptor beta chain mRNA expression in IFN-alpha-responsive chronic myelogenous leukaemia patients

May 8, 1999·British Journal of Haematology·T ShimomuraM Kawakita

Comparative cytogenetic studies of benign, borderline, and malignant epithelial ovarian tumors

Dec 1, 1996·The Journal of Obstetrics and Gynaecology Research·T IzutsuI Nishiya

Discussion paper: the role of cytogenetics in mutagenesis testing

Dec 31, 1975·Annals of the New York Academy of Sciences·K Hirschhorn

Acute myeloblastic leukemia with associated BCR-ABL translocation in a dog

Jul 4, 2012·Veterinary Clinical Pathology·Josely F FigueiredoKristen R Friedrichs

Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization

Oct 26, 1990·Science·D C TkachukD Pinkel

Inhibition of polysome assembly enhances imatinib activity against chronic myelogenous leukemia and overcomes imatinib resistance

Aug 13, 2008·Molecular and Cellular Biology·Min ZhangS Tiong Ong

Nanocolonies and diagnostics of oncological diseases associated with chromosomal translocations

Mar 23, 2011·Biochemistry. Biokhimii︠a︡·E V Chetverina, A B Chetverin

Successful pregnancy in a patient with chronic myeloid leukaemia exposed to dasatinib during the first trimester

Jan 1, 2010·BMJ Case Reports·Soley BayraktarMaricer P Escalón

Letter: Consistent chromosome abnormalities in acute leukaemia

Oct 26, 1974·British Medical Journal·J H FordF W Gunz

Aneuploidy and malignancy: an unsolved equation

Nov 26, 2004·Journal of Clinical Pathology·P Dey

Agar culture and chromosome analysis of eosinophilic leukaemia

Dec 1, 1975·Journal of Clinical Pathology·J M GoldmanK H Th'ng

Chromosome studies in man: past achievements and recent advances

Jul 1, 1976·Journal of Clinical Pathology·S D Lawler, B R Reeves

Abnormal distribution of c-myc oncogene product in familial adenomatous polyposis

Nov 1, 1987·Journal of Clinical Pathology·V SundaresanJ V Watson

Absence of the 9q plus chromosome in Ph1 negative chronic myelogenous leukaemia

Jun 1, 1974·Journal of Medical Genetics·Janet D Rowley

Female phenotype and multiple abnormalities in sibs with a Y chromosome and partial X chromosome duplication: H--Y antigen and Xg blood group findings

Aug 1, 1980·Journal of Medical Genetics·R BernsteinS S Wachtel

Human chromosome 22

Feb 1, 1987·Journal of Medical Genetics·J C KaplanM F Szajnert

Molecular genetics of neurological tumours

Jun 1, 1992·Journal of Medical Genetics·R Y Chung, B R Seizinger

Methods of molecular analysis: assessing losses and gains in tumours

Feb 12, 2002·Molecular Pathology : MP·R Roylance

From cytogenetics to next-generation sequencing technologies: advances in the detection of genome rearrangements in tumors

Apr 30, 2008·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Olena Morozova, Marco A Marra

Chromosomes in leukemia and beyond: from irrelevant to central players

Sep 1, 2009·Annual Review of Genomics and Human Genetics·Janet D Rowley

The critical role of chromosome translocations in human leukemias

Feb 3, 1999·Annual Review of Genetics·Janet D Rowley

Clinical utility of contemporary molecular cytogenetics

Oct 25, 2008·Annual Review of Genomics and Human Genetics·Bassem A Bejjani, Lisa G Shaffer

The BCR-ABL story: bench to bedside and back

Mar 23, 2004·Annual Review of Immunology·S Wong, O N Witte

Tyrosine kinase inhibitors and the dawn of molecular cancer therapeutics

Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Raoul TibesR Kurzrock

New complex chromosomal translocation in chronic myeloid leukaemia: t(9;18;22)(q34;p11;q11)

Feb 15, 2008·Journal of Biomedicine & Biotechnology·Abdeljabar El Andaloussi, Chrystele Bilhou-Nabera

The use of imatinib mesylate as a lifesaving treatment of chronic myeloid leukemia relapse after bone marrow transplantation

Jan 29, 2010·Journal of Transplantation·Monika ConchonFrederico Luiz Dulley

Clinical implementation of comprehensive strategies to characterize cancer genomes: opportunities and challenges

Sep 22, 2011·Cancer Discovery·Laura E MacconaillWilliam C Hahn

Identification of targetable FGFR gene fusions in diverse cancers

Apr 6, 2013·Cancer Discovery·Yi-Mi WuArul M Chinnaiyan

High expression of bcl-x(L) in K562 cells and its role in the low sensitivity of K562 to realgar-induced apoptosis

Jun 29, 2005·Acta Haematologica·Jing ZhangLi-Bo Yao

Natural history of Southeast Asian chronic myeloid leukemia patients with different BCR-ABL gene variants

Aug 18, 2006·Acta Haematologica·C U AuewarakulS Boonmoh

The genetics of bladder cancer: a cytogeneticist's perspective

Nov 15, 2007·Cytogenetic and Genome Research·D J Wolff

The mystery of chromosomal translocations in cancer

Nov 15, 2007·Cytogenetic and Genome Research·L G Koss

Mutant molecules of interest in myeloproliferative neoplasms: introduction

Jun 21, 2008·Acta Haematologica·Ayalew Tefferi

JAK2 and MPL mutations in myeloproliferative neoplasms

Jun 21, 2008·Acta Haematologica·Priya Koppikar, Ross L Levine

Dasatinib overrides imatinib resistance mediated by the F359I residue mutation in two patients with chronic myeloid leukemia

Nov 19, 2011·Acta Haematologica·Mariana SerpaIsrael Bendit

Imatinib and beyond--targeting activated tyrosine kinases in myeloproliferative disorders

Feb 1, 2012·Onkologie·Andreas HochhausPaul La Rosée

Evaluation of long-term outcomes, cytogenetic and molecular responses with imatinib mesylate in early and late chronic-phase chronic myeloid leukemia: a report from a single institute

Aug 28, 2012·Acta Haematologica·Israel BenditDalton de Alencar Fischer Chamone

Don't Mess with RUNX1

Dec 15, 2012·Molecular Syndromology·M Poot

In vivo differentiation of blast-phase chronic granulocytic leukemia. Expression of c-myc and c-abl protooncogenes

Jul 1, 1985·The Journal of Clinical Investigation·C A KollerD M Miller

Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis

Nov 1, 1986·The Journal of Clinical Investigation·S J Collins

The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia

Jun 1, 1991·The Journal of Clinical Investigation·H AhujaM J Cline

Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation

Oct 1, 1993·The Journal of Clinical Investigation·M WetzlerR Kurzrock

BCR/ABL induces multiple abnormalities of cytoskeletal function

Jul 1, 1997·The Journal of Clinical Investigation·R SalgiaJ D Griffin

FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia

Aug 25, 2007·The Journal of Clinical Investigation·Paolo NevianiDanilo Perrotti

Treatment for chronic myelogenous leukemia: the long road to imatinib

Aug 3, 2007·The Journal of Clinical Investigation·Tony Hunter

Applying the discovery of the Philadelphia chromosome

Aug 3, 2007·The Journal of Clinical Investigation·Daniel W Sherbenou, Brian J Druker

ErbB receptors: from oncogenes to targeted cancer therapies

Aug 3, 2007·The Journal of Clinical Investigation·Hongtao ZhangMark I Greene

Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications

Aug 3, 2007·The Journal of Clinical Investigation·George A Calin, Carlo M Croce

Stem cells in prostate cancer initiation and progression

Aug 3, 2007·The Journal of Clinical Investigation·Devon A Lawson, O N Witte

The legacy of the Philadelphia chromosome

Aug 3, 2007·The Journal of Clinical Investigation·Gary A Koretzky

Following the cytokine signaling pathway to leukemogenesis: a chronology

Nov 5, 2008·The Journal of Clinical Investigation·Kendall A Smith, J D Griffin

Translational research: are we on the right track? 2008 American Society for Clinical Investigation Presidential Address

Nov 5, 2008·The Journal of Clinical Investigation·Charles L Sawyers

CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression

Jan 11, 2012·The Journal of Clinical Investigation·Christian SchürchAdrian F Ochsenbein

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

Jan 5, 2000·The Journal of Clinical Investigation·Brian J Druker, N B Lydon

Evolutionary dynamics of chronic myeloid leukemia

Apr 1, 2010·Genes & Cancer·David DingliJorge M Pacheco

From Hen House to Bedside: Tracing Hanafusa's Legacy from Avian Leukemia Viruses to SRC to ABL and Beyond

Jul 23, 2011·Genes & Cancer·Michael G Kharas, G Q Daley

Philadelphia chromosome positive acute lymphocytic leukemia: a new era of challenges

Nov 21, 2007·Hematology·Deborah A Thomas

Tyrosine kinase inhibitor use in pediatric Philadelphia chromosome-positive acute lymphoblastic anemia

Dec 14, 2011·Hematology·Stephen P Hunger

ABCs of genomics

Dec 10, 2013·Hematology·Stefan K Bohlander

Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells

Jan 19, 2006·Blood·Clara GuerzoniBruno Calabretta

Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPalpha

May 4, 2006·Blood·Giovanna Ferrari-AmorottiBruno Calabretta

Activation of a novel Bcr/Abl destruction pathway by WP1130 induces apoptosis of chronic myelogenous leukemia cells

Jan 5, 2007·Blood·Geoffrey A BartholomeuszNicholas J Donato

SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl

Sep 28, 2006·Blood·Jing ChenCheng-Kui Qu

Role of BCR/ABL gene-expression levels in determining the phenotype and imatinib sensitivity of transformed human hematopoietic cells

Mar 10, 2007·Blood·Hardik ModiR Bhatia

Ubp43 regulates BCR-ABL leukemogenesis via the type 1 interferon receptor signaling

Mar 22, 2007·Blood·Ming YanDong-Er Zhang

X-linked clonality testing: interpretation and limitations

Apr 17, 2007·Blood·George L Chen, Josef T Prchal

Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib

Nov 21, 2007·Blood·Matthias MayerhoferPeter Valent

Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia

Jun 8, 2007·Blood·Robert A J SignerKenneth Dorshkind

Enhanced expression of p210BCR/ABL and aberrant expression of Zfp423/ZNF423 induce blast crisis of chronic myelogenous leukemia

Feb 24, 2009·Blood·Kazuko MiyazakiHiroaki Honda

Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: a phase 2 trial of the GIMEMA CML Working Party

Feb 13, 2009·Blood·Fausto CastagnettiGIMEMA CML Working Party

Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis

Jan 30, 2008·Blood·Maria Rosa LidonniciBruno Calabretta

Acute dasatinib exposure commits Bcr-Abl-dependent cells to apoptosis

Aug 27, 2009·Blood·Jennifer L SneadMichael W Deininger

Myeloproliferative disorders

Sep 10, 2008·Blood·Ross L Levine, D Gary Gilliland

BMS-214662 induces mitochondrial apoptosis in chronic myeloid leukemia (CML) stem/progenitor cells, including CD34+38- cells, through activation of protein kinase Cbeta

Sep 10, 2009·Blood·Francesca PellicanoTessa L Holyoake

Chronic myeloid leukemia: a prospective comparison of interphase fluorescence in situ hybridization and chromosome banding analysis for the definition of complete cytogenetic response: a study of the GIMEMA CML WP

Oct 3, 2009·Blood·N TestoniMichele Baccarani

Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines

Jun 21, 2011·Blood·Debasmita RoyDirk P Dittmer

Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis

Jun 14, 2012·Blood·Simona LuattiGruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Working Party on CML

Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor

Dec 9, 2010·BMC Blood Disorders·Gyan K KayasthaAaron S Mansfield

Knock-down of Kaiso induces proliferation and blocks granulocytic differentiation in blast crisis of chronic myeloid leukemia

Jun 20, 2012·Cancer Cell International·Jaime CofreEliana Abdelhay

Two successful pregnancies in a woman with chronic myeloid leukemia exposed to nilotinib during the first trimester of her second pregnancy: case study

Oct 8, 2009·Journal of Hematology & Oncology·Monika ConchonPedro Enrique Dorliac-Llacer

Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease

Apr 15, 2004·American Journal of Clinical Pathology·Maria-Theresa KrauthPeter Valent

t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia

Jun 17, 2004·American Journal of Clinical Pathology·C Cameron YinPei Lin

Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib

Sep 15, 2009·PLoS Computational Biology·Jasmine FooFranziska Michor

RNA-Seq mapping and detection of gene fusions with a suffix array algorithm

Apr 13, 2012·PLoS Computational Biology·Onur SakaryaAsim S Siddiqui

Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types

May 3, 2013·PLoS Genetics·Craig P GiacominiJonathan R Pollack

Dynamics of resistance development to imatinib under increasing selection pressure: a combination of mathematical models and in vitro data

Jan 5, 2012·PloS One·Benjamin WernerStefan Balabanov

Extensive gene-specific translational reprogramming in a model of B cell differentiation and Abl-dependent transformation

Jun 14, 2012·PloS One·Jamie G BatesPat O Brown

Carboxyamidotriazole-orotate inhibits the growth of imatinib-resistant chronic myeloid leukaemia cells and modulates exosomes-stimulated angiogenesis

Aug 11, 2012